Study Description: There is an extensive body of knowledge that indicates premenopausal women have an innate protection from cardiovascular disease and estrogen is what contributes to this protection (1,2). In contrast to these protective findings in humans, using an animal model, estrogen in diabetes has been indicated to contribute to vasoconstriction. Taken together, the purpose of this proposal is to investigate whether or not estrogen contributes to vascular dysfunction in premenopausal women with diabetes.
Principal Investigator: Ryan Harris
Eligibility Criteria: Amendment 4: Adults (18-40 years old) All races Regular menses Clinical diagnosis of diabetes Initial Study: Participants must be at least 18 years of age Female participants may not be pregnant or postmenopausal Participant must have a clinical diagnosis of diabetes
Compensation: Yes, subjects will be compensated.
Compensation Explanation: Subjects will be paid a total of $300 for the completion of this study.
If you don't see specific studies that interest you, please submit your contact information for future studies.